Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Strack-Logue B"'
Autor:
Dwyer B; Takeda Pharmaceuticals, Cambridge, MA, 02140, USA. Electronic address: brian.dwyer@Takeda.com., Lundberg D; Takeda Pharmaceuticals, Cambridge, MA, 02140, USA., Iskenderian A; Takeda Pharmaceuticals, Cambridge, MA, 02140, USA., Strack-Logue B; Takeda Pharmaceuticals, Cambridge, MA, 02140, USA., Pescatore B; Takeda Pharmaceuticals, Cambridge, MA, 02140, USA., Norton AW; Takeda Pharmaceuticals, Cambridge, MA, 02140, USA., Xu J; University of Massachusetts, Lowell, MA, 01854, USA., Meiyappan M; Takeda Pharmaceuticals, Cambridge, MA, 02140, USA., Concino MF; Takeda Pharmaceuticals, Cambridge, MA, 02140, USA., Zhang B; Takeda Pharmaceuticals, Cambridge, MA, 02140, USA.
Publikováno v:
Protein expression and purification [Protein Expr Purif] 2020 Jun; Vol. 170, pp. 105589. Date of Electronic Publication: 2020 Feb 03.
Autor:
Risti, Robert1, Reimund, Mart1, Seeba, Natjan-Naatan1, Lõokene, Aivar1 aivar.lookene@taltech.ee
Publikováno v:
Scientific Reports. 8/23/2024, Vol. 14 Issue 1, p1-11. 11p.
Autor:
Birrane G; Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215., Beigneux AP; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095., Dwyer B; Discovery Therapeutics, US Drug Discovery, Shire Pharmaceuticals, Cambridge, MA 02142., Strack-Logue B; Discovery Therapeutics, US Drug Discovery, Shire Pharmaceuticals, Cambridge, MA 02142., Kristensen KK; Finsen Laboratory, Rigshospitalet, DK-2200 Copenhagen, Denmark.; Biotech Research and Innovation Centre, University of Copenhagen, DK-2200 Copenhagen, Denmark., Francone OL; Discovery Therapeutics, US Drug Discovery, Shire Pharmaceuticals, Cambridge, MA 02142., Fong LG; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095., Mertens HDT; BIOSAXS Group, European Molecular Biology Laboratory Hamburg, D-22607 Hamburg, Germany., Pan CQ; Discovery Therapeutics, US Drug Discovery, Shire Pharmaceuticals, Cambridge, MA 02142., Ploug M; Finsen Laboratory, Rigshospitalet, DK-2200 Copenhagen, Denmark.; Biotech Research and Innovation Centre, University of Copenhagen, DK-2200 Copenhagen, Denmark., Young SG; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; sgyoung@mednet.ucla.edu mmeiyappan@shire.com., Meiyappan M; Discovery Therapeutics, US Drug Discovery, Shire Pharmaceuticals, Cambridge, MA 02142; sgyoung@mednet.ucla.edu mmeiyappan@shire.com.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Jan 29; Vol. 116 (5), pp. 1723-1732. Date of Electronic Publication: 2018 Dec 17.
Autor:
Shen C; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Iskenderian A; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Lundberg D; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., He T; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Palmieri K; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Crooker R; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Deng Q; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Traylor M; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Gu S; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Rong H; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Ehmann D; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Pescatore B; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Strack-Logue B; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Romashko A; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Baviello G; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Gill J; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Zhang B; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Meiyappan M; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Pan C; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.)., Norton AW; Departments of Discovery Therapeutics (C.S., A.I., D.L., B.P., B.S.-L., A.R., G.B., J.G., B.Z., M.M., C.P., A.W.N.), Bioanalytical and Biomarker Development (T.H.), Discovery Biology and Translational Research (K.P., R.C., Q.D., D.E.), Analytical Development (M.T., S.G.), and Drug Metabolism and Pharmacokinetics (H.R.), Shire, Lexington, Massachusetts (H.R.) anorton@shire.com.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2018 Aug; Vol. 366 (2), pp. 291-302. Date of Electronic Publication: 2018 May 11.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Risti, Robert1 (AUTHOR), Gunn, Kathryn H.2 (AUTHOR), Hiis-Hommuk, Kristofer3 (AUTHOR), Seeba, Natjan-Naatan1 (AUTHOR), Karimi, Hamed3 (AUTHOR), Villo, Ly1 (AUTHOR), Vendelin, Marko3 (AUTHOR), Neher, Saskia B.2 (AUTHOR), Lõokene, Aivar1 (AUTHOR) aivar.lookene@taltech.ee
Publikováno v:
PLoS ONE. 4/12/2023, Vol. 17 Issue 4, p1-24. 24p.
Autor:
Dagli-Hernandez, Carolina, Ferreira, Glaucio Monteiro, Freitas, Renata Caroline Costa de, Borges, Jessica Bassani, Oliveira, Victor Fernandes de, Gonçalves, Rodrigo Marques, Faludi, Andre Arpad, Marçal, Elisangela da Silva Rodrigues, Bastos, Gisele Medeiros, Bortolin, Raul Hernandes, Hirata, Mario Hiroyuki, Hirata, Rosario Dominguez Crespo
Publikováno v:
Pharmacogenetics & Genomics; Jun2024, Vol. 34 Issue 4, p91-104, 14p
Autor:
Heo, Yunseok1 (AUTHOR) uoonsek1@yonsei.ac.kr, Lee, Inhwan1 (AUTHOR) inhwan@kolmar.co.kr, Moon, Sunjin1 (AUTHOR) moon@spin.yonsei.ac.kr, Yun, Ji-Hye1,2 (AUTHOR) jihye2@spin.yonsei.ac.kr, Kim, Eun Yu3 (AUTHOR) eunyukim@cemps.ac.cn, Park, Sam-Yong4 (AUTHOR) park@yokohama-cu.ac.jp, Park, Jae-Hyun1 (AUTHOR) jhpark@spin.yonsei.ac.kr, Kim, Woo Taek3 (AUTHOR) wtkim@yonsei.ac.kr, Lee, Weontae1,2 (AUTHOR) wtkim@yonsei.ac.kr
Publikováno v:
Molecules. Apr2022, Vol. 27 Issue 7, p2317-2317. 13p.
Targeting host-specific metabolic pathways--opportunities and challenges for anti-infective therapy.
Publikováno v:
Frontiers in Molecular Biosciences; 2024, p1-19, 19p
Publikováno v:
Frontiers in Cellular & Infection Microbiology; 2024, p1-10, 10p